D
David A. Liebner
Researcher at Ohio State University
Publications - 66
Citations - 1320
David A. Liebner is an academic researcher from Ohio State University. The author has contributed to research in topics: Medicine & Sarcoma. The author has an hindex of 15, co-authored 48 publications receiving 790 citations. Previous affiliations of David A. Liebner include The Ohio State University Wexner Medical Center & State University of New York System.
Papers
More filters
Journal ArticleDOI
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Margaret von Mehren,John M. Kane,Mark Agulnik,Marilyn M. Bui,Janai Carr-Ascher,Edwin Choy,Mary Connelly,Sarah Dry,Kristen N. Ganjoo,Ricardo J. Gonzalez,Ashley M. Holder,Jade Homsi,Vicki L. Keedy,Ciara Marie Kelly,Edward S. Kim,David A. Liebner,Martin M McCarter,Sean V. McGarry,Nathan W. Mesko,Christian F. Meyer,Alberto S. Pappo,Amanda Parkes,Ivy A. Petersen,Seth M. Pollack,Matthew M. Poppe,Richard F. Riedel,Scott M. Schuetze,Jacob E. Shabason,Jason K. Sicklick,Matthew B. Spraker,Melissa Zimel,Lisa E Hang,Hema Sundar,Mary Anne Bergman +33 more
TL;DR: This portion of the NCCN Guidelines discusses general principles for the diagnosis and treatment of retroperitoneal/intra-abdominal STS, outlines treatment recommendations, and reviews the evidence to support the guidelines recommendations.
Journal ArticleDOI
Soft Tissue Sarcoma, Version 1.2021: Featured updates to the NCCN guidelines
Margaret von Mehren,John M. Kane,Marilyn M. Bui,Edwin Choy,Mary Connelly,Sarah M. Dry,Kristen N. Ganjoo,Suzanne George,Ricardo J. Gonzalez,Martin J. Heslin,Jade Homsi,Vicki L. Keedy,Ciara Marie Kelly,Edward Kim,David A. Liebner,Martin D. McCarter,Sean V. McGarry,Christian F. Meyer,Alberto S. Pappo,Amanda Parkes,I. Benjamin Paz,Ivy A. Petersen,Matthew M. Poppe,Richard F. Riedel,Brian P. Rubin,Scott M. Schuetze,Jacob E. Shabason,Jason K. Sicklick,Matthew B. Spraker,Melissa Zimel,Mary Anne Bergman,Giby V. George +31 more
TL;DR: The panel discussion behind recent important updates to the NCCN Guidelines Insights summary the development of a separate and distinct guideline for gastrointestinal stromal tumors (GISTs), reconception of the management of desmoid tumors, and revision of the principles of radiation therapy for soft tissue sarcomas are summarized.
Journal ArticleDOI
Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases
Noelle L. Williams,Evan Wuthrick,Hyun Kim,Joshua D. Palmer,Shivank Garg,Harriet Eldredge-Hindy,Constantine Daskalakis,Kendra J. Feeney,Michael J. Mastrangelo,Lyndon Kim,Takami Sato,Kari Kendra,Thomas Olencki,David A. Liebner,Christopher J. Farrell,James J. Evans,Kevin Judy,David W. Andrews,Adam P. Dicker,Maria Werner-Wasik,Wenyin Shi +20 more
TL;DR: A phase 1 study to determine the maximum tolerable dose and safety of ipilimumab with stereotactic radiosurgery (SRS) or whole brain radiation therapy (WBRT) in patients with brain metastases from melanoma demonstrated safety and overall survival.
Injury, Large-Scale Collaborative Research Program
Carol L. Miller-Graziano,Ronald V. Maier,David A. Schoenfeld,Wenzhong Xiao,Lyle L. Moldawer,J. Perren Cobb,Bernard H. Brownstein,Adrian Fay,Sandra MacMillan,Robert J. Feezor,Henry V. Baker,Michael N. Mindrinos,Doug Hayden,L Cynthia,David A. Liebner,Kun Huang,Jeffrey D. Parvin +16 more
Journal ArticleDOI
MMAD: microarray microdissection with analysis of differences is a computational tool for deconvoluting cell type-specific contributions from tissue samples
TL;DR: A new computational tool called MMAD, which is capable of performing robust tissue microdissection in silico, and which can improve the detection of differentially expressed genes, is developed.